Redcare Pharmacy NV provided earnings guidance for the full year 2023. For the year, the company confirmed the guidance of net sales EUR 1.7 billion to EUR 1.8 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
120 EUR | -0.04% | -4.62% | -9.04% |
Apr. 26 | REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating | ZD |
Apr. 26 | REDCARE PHARMACY : Hauck & Aufhauser keeps its Buy rating | ZD |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.04% | 2.63B | |
-20.84% | 12.31B | |
-24.53% | 6.59B | |
+12.51% | 6.3B | |
-8.87% | 5.88B | |
-1.61% | 4.74B | |
+60.03% | 4.7B | |
-4.98% | 4.03B | |
-8.76% | 3.58B | |
-7.32% | 3.07B |
- Stock Market
- Equities
- RDC Stock
- News Redcare Pharmacy NV
- Redcare Pharmacy NV Provides Earnings Guidance for the Full Year 2023